Published in Blood Weekly, March 8th, 1999
In a letter from FDA, the agency said Home Access Health's "Hepatitis C Check" test service was granted expedited review status because "the device may meet some specific public health needs in making available counseling and information on hepatitis C status information to a broader public."
The agency specifically mentioned the current hepatitis C "Lookback Guidance" as one of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.